Sirolimus protein-bound Alternatives Compared
Sirolimus protein-bound | Fyarro (sirolimus protein-bound) |
|
---|
Sirolimus protein-bound | Fyarro (sirolimus protein-bound) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Malignant Perivascular Epithelioid Cell Tumor. Sirolimus protein-bound may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malignant Perivascular Epithelioid Cell Tumor. Fyarro may also be used for purposes not listed in this medication guide. |
||||||||
More about Sirolimus protein-bound | More about Fyarro (sirolimus protein-bound) | ||||||||
Ratings & Reviews | |||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Sirolimus protein-bound side effects |
View all Fyarro side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Fyarro prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Fyarro |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
59 hours |
59 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 413 drugs are known to interact with Sirolimus protein-bound:
|
A total of 413 drugs are known to interact with Fyarro:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.